25 May 2020: Sysmex Donates ¥30 Million to Kobe City Support Fund for Medical Professionals to Support COVID-19 Countermeasures

Our thoughts and prayers are with the families of those who have perished as a result of the novel coronavirus (COVID-19), and we offer our heartfelt sympathy to the patients currently suffering from this disease. We are truly grateful for the efforts of the medical community and all others who are working on the front lines to stop this pandemic from spreading. Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has decided to donate ¥30 million to the Kobe City Support Fund for Medical Professionals to support measures for countering COVID-19.

18 May 2020: The City of Kobe, Sysmex, and SRL Configure and Begin Operating a PCR Testing System for COVID-19 within the Kobe Biomedical Innovation Cluster

The City of Kobe (Location: Kobe, Japan; Mayor: Kizo Hisamoto), Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and SRL, Inc. (HQ: Shinjuku-ku, Tokyo, Japan; President and CEO: Shunichi Higashi), a subsidiary of Miraca Holdings Inc., hereby provide notice of the configuration of a PCR testing system within the Kobe Biomedical Innovation Cluster for the novel coronavirus (COVID-19). Operations are slated to commence on June 1, 2020.

11 May 2020: Sysmex New Zealand and ESR collaborate on national COVID-19 results CDR

Within hours of New Zealand lifting to alert level 4, a collaborative project was initiated between the Institute of Environmental Science and Research (ESR) and Sysmex New Zealand to establish a national clinical data repository (CDR) for all COVID-19 test reports from testing lab facilities across the country. ESR provide an extensive range of scientific […]